Who decides whether a drug can be used off-label and under what circumstances? If a physician decides to prescribe a drug off-label, what legal issues, if any, should the physician be aware of? With the increased practice of prescribing drugs for off-label use, coupled with a somewhat dated and incomplete medical negligence standard in Minnesota, the intersection of the off-label use doctrine with Minnesota’s medical negligence standard is ripe for review. This article examines the off-label use doctrine and the medical negligence standard under Minnesota law. First, the article examines what the phrase “off-label use” means. Next, the article explores the cases that have arisen in Minnesota which address medical malpractice claims arising,...
Physicians can prescribe medicines for different indications than the tested and authorised ones. Su...
European Union (EU) legislation on marketing authorisation of medicinal products aims to safeguard p...
Prescribing a medication for a condition not described in the label approved by national regulatory ...
Who decides whether a drug can be used off-label and under what circumstances? If a physician decide...
INTRODUCTION Even if shortly, this article deals with a question that is still largely unexplored by...
So-called ‘‘off label’ ’ and unlicensed prescribing refers to the use of medicines outside of the in...
Background: Medicine use is considered off-label when used for an indication, at a dose, via a route...
• Off-label prescribing is the prescription of a registered medicine for a use that is not included ...
This book examines the regulatory framework for untested and unapproved uses (off-label uses) of med...
Off label prescription occurs when a drug is prescribed for an indication, a route of administratio...
Off-label use (OLU) is defined as the prescription of pharmaceutical drugs for an indication or othe...
Background and Aim: Off-label prescribing involves the use of medicines in a manner that has not bee...
For many years, the off-label use of drugs has been a debated issue for healthcare administrators, ...
World experience in off-label medicines use is presented in the article. Data on the history of chan...
The current state of the Russian and foreign regulatory framework for off-label prescription of medi...
Physicians can prescribe medicines for different indications than the tested and authorised ones. Su...
European Union (EU) legislation on marketing authorisation of medicinal products aims to safeguard p...
Prescribing a medication for a condition not described in the label approved by national regulatory ...
Who decides whether a drug can be used off-label and under what circumstances? If a physician decide...
INTRODUCTION Even if shortly, this article deals with a question that is still largely unexplored by...
So-called ‘‘off label’ ’ and unlicensed prescribing refers to the use of medicines outside of the in...
Background: Medicine use is considered off-label when used for an indication, at a dose, via a route...
• Off-label prescribing is the prescription of a registered medicine for a use that is not included ...
This book examines the regulatory framework for untested and unapproved uses (off-label uses) of med...
Off label prescription occurs when a drug is prescribed for an indication, a route of administratio...
Off-label use (OLU) is defined as the prescription of pharmaceutical drugs for an indication or othe...
Background and Aim: Off-label prescribing involves the use of medicines in a manner that has not bee...
For many years, the off-label use of drugs has been a debated issue for healthcare administrators, ...
World experience in off-label medicines use is presented in the article. Data on the history of chan...
The current state of the Russian and foreign regulatory framework for off-label prescription of medi...
Physicians can prescribe medicines for different indications than the tested and authorised ones. Su...
European Union (EU) legislation on marketing authorisation of medicinal products aims to safeguard p...
Prescribing a medication for a condition not described in the label approved by national regulatory ...